mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.009 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.009 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |